Detalhe da pesquisa
1.
Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocol.
Muscle Nerve
; 67(5): 354-362, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533976
2.
Disruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte development.
Immunity
; 36(5): 769-81, 2012 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22608497
3.
A forward-genetic approach for analysis of the immune system.
Nat Rev Immunol
; 3(6): 463-71, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12776206
4.
Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis.
Medicine (Baltimore)
; 100(42): e27421, 2021 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34678870
5.
Importance of the TIMI frame count: implications for future trials.
Curr Control Trials Cardiovasc Med
; 1(1): 31-34, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-11714404
6.
Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial.
J Invasive Cardiol
; 14(6): 299-302, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12042618
7.
Engineering of stable bispecific antibodies targeting IL-17A and IL-23.
Protein Eng Des Sel
; 23(3): 115-27, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20022918
8.
Key developments in cardiovascular medicine.
Practitioner
; 246(1635): 375-7, 380-2, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12073696
9.
CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance.
J Exp Med
; 206(2): 421-34, 2009 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19188497
10.
A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic protein 1 in lymphopoiesis and innate immunity.
J Exp Med
; 205(12): 2899-913, 2008 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19015308
11.
Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F.
J Immunol
; 179(8): 5462-73, 2007 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17911633
12.
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.
EMBO J
; 22(23): 6267-76, 2003 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14633986
13.
A novel mutation in CD83 results in the development of a unique population of CD4+ T cells.
J Immunol
; 173(5): 2995-3001, 2004 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15322158